Literature DB >> 9790117

Primary cutaneous synovial sarcoma: a case report.

D B Flieder1, C A Moran.   

Abstract

We present a case of synovial sarcoma involving the cutaneous tissue of the knee in an 18-year-old woman. The 2.5 cm tumor was locally excised and recurred six times over the following 24 years. The neoplasm involved the deep dermis with extension into the papillary dermis and superficial subcutis. The tumor was predominantly composed of spindle cells arranged in compact interdigitating fascicles and scattered epithelial nests were seen. Focal myxoid and hemangiopericytoma-like areas as well as numerous mast cells were identified. Spindle cells stained for vimentin, CAM 5.2, and epithelial membrane antigen, whereas epithelial nests only stained for CAM 5.2 and epithelial membrane antigen. Neither component was reactive for antibodies directed against desmin, muscle specific actin, smooth muscle actin, S-100 protein, CD-31, or CD-34. This newly reported location for this morphologically heterogeneous tumor creates potential diagnostic confusion with other primary neoplasms in these areas.

Entities:  

Mesh:

Year:  1998        PMID: 9790117     DOI: 10.1097/00000372-199810000-00017

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  3 in total

1.  Malignant inguinal monophasic synovial sarcoma: report of a case and review of the literature.

Authors:  Ji Xu; Jia Wang; Long Cui; Xiangru Wu
Journal:  World J Surg Oncol       Date:  2010-11-21       Impact factor: 2.754

2.  A practical and comprehensive immunohistochemical approach to the diagnosis of superficial soft tissue tumors.

Authors:  Wael Al-Daraji; Ehab Husain; Bettena G Zelger; Bernhard Zelger
Journal:  Int J Clin Exp Pathol       Date:  2008-06-10

3.  Primary Cutaneous Synovial Sarcoma: An Extremely Rare Report of Superficial Synovial Sarcoma.

Authors:  Nastaran Namazi; Morteza Ghassemipour; Azadeh Rakhshan; Ata Abbasi
Journal:  Indian J Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.